Burosumab Biosimilar - Research Grade
Product Specifications
Background
Uses the same sequence as the therapeutic antibody Burosumab
Reactivity
Human
Target
FGF23
Sequence
https://www.imgt.org/mAb-DB/
Applications
Functional Assays
Purification Method
This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Concentration
5mg/mL
Endotoxin
<1EU/mg Determined by LAL gel clotting assay
Purity
≥95% monomer by analytical SEC, >95% by SDS Page
Buffer
ICH3002
Shipping Conditions
Blue ice
Storage Conditions
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Fragment
Human IgG1 (E356D/M358L) -kappa
Specificity
Detects human FGF23
Formulation
Sterile, preservative-free, solution in PBS. BSA and Azide free.
Applications Notes
This biosimilar is for research use only (RUO) : it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Isotype Control
ICH2254EDML
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
HNF4A (Hepatocyte Nuclear Factor 4, alpha, HNF4-alpha, OTTHUMP00000031060, OTTHUMP00000031062, Hepatic Nuclear Factor 4 alpha, Hepatocyte Nuclear Factor 4 alpha, Transcription Factor-14, FLJ39654, HNF4, HNF4a7, HNF4a8, HNF4a9, MODY, MODY1, NR2A1, NR2A21, TCF, TCF14) (MaxLight 490)